Alphamab Oncology Dividend
Dividend criteria checks 0/6
Alphamab Oncology does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 1.1% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -HK$0.22 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Alphamab Oncology's (HKG:9966) Shares Climb 27% But Its Business Is Yet to Catch Up
May 06Optimistic Investors Push Alphamab Oncology (HKG:9966) Shares Up 27% But Growth Is Lacking
Mar 13Subdued Growth No Barrier To Alphamab Oncology's (HKG:9966) Price
Jan 17Slammed 40% Alphamab Oncology (HKG:9966) Screens Well Here But There Might Be A Catch
May 21Newsflash: Alphamab Oncology (HKG:9966) Analysts Have Been Trimming Their Revenue Forecasts
Mar 01Is Alphamab Oncology (HKG:9966) Using Debt Sensibly?
Oct 04Is Alphamab Oncology (HKG:9966) A Risky Investment?
May 21Rock star Growth Puts Alphamab Oncology (HKG:9966) In A Position To Use Debt
Oct 05Is Alphamab Oncology (HKG:9966) Using Too Much Debt?
May 05How Many Alphamab Oncology (HKG:9966) Shares Have Insiders Sold, In The Last Year?
Feb 09Should Alphamab Oncology (HKG:9966) Be Disappointed With Their 19% Profit?
Dec 30What Percentage Of Alphamab Oncology (HKG:9966) Shares Do Insiders Own?
Nov 25Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 9966's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 9966's dividend payments have been increasing.
Dividend Yield vs Market
Alphamab Oncology Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (9966) | n/a |
Market Bottom 25% (HK) | 3.1% |
Market Top 25% (HK) | 7.5% |
Industry Average (Biotechs) | 1.1% |
Analyst forecast in 3 Years (9966) | 0% |
Notable Dividend: Unable to evaluate 9966's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 9966's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 9966's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 9966 has not reported any payouts.